Legacy Genedx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Legacy genedx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Legacy Genedx Today - Breaking & Trending Today

TD Cowen Adjusts GeneDx Holdings' Price Target to $24 From $14, Keeps Buy Rating

Price: 17.32, Change: +6.32, Percent Change: +57.45
. ....

Genedx Holdings Corp , Genedx Holdings , Legacy Genedx , Legacy Sema ,

GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024

Reported fourth quarter 2023 revenue from continuing operations1 of $58.1M with more than 68% year-over-year growth of exome and genome test revenue Expanded fourth quarter 2023 adjusted gross. ....

United States , New York , Katherine Stueland , American Epilepsy Society Annual Meeting , Globenewswire Inc , Google Health , Exchange Commission , Company Class , York Center , American College Of Medical Genetics , University Of Washington , Genedx Holdings Corp , Chief Executive Officer , Full Year , Legacy Sema , Legacy Genedx , Epilepsy Society Annual Meeting , Medical Genetics , Rare Diseases , Chief Growth Officer , Chief Product , Conference Call , Annual Report , Relations Contact , Select Financial Information ,

GeneDx Reports Fourth Quarter and Full Year 2023 Financial

GeneDx Holdings Corp. (Nasdaq: WGS) reported its financial results for the fourth quarter and full year of 2023.. ....

United States , New York , Katherine Stueland , American College Of Medical Genetics , Company Class , Genedx Holdings Corp , American Epilepsy Society Annual Meeting , Exchange Commission , Google Health , York Center , University Of Washington , Chief Executive Officer , Full Year , Legacy Sema , Legacy Genedx , American College , Medical Genetics , New York Center , Rare Diseases , Melanie Duquette , Chief Growth Officer , Eric Olivares , Chief Product , Conference Call , Annual Report , Relations Contact ,

GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights

Reported total revenue of $53M with more than 40% year-over-year growth of exome and genome test revenue Expanded gross margins to 48% in continuing operations and delivered 52% year-over-year. ....

United States , Katherine Stueland , Exchange Commission , Genedx Holdings Corp , American Society Of Human Genetics , Research Development , Globenewswire Inc , Cost Of Services , Chief Executive Officer , Quarter Financial , Legacy Sema , Genedx Full Year , Chief Growth Officer , Closing Date , Human Genetics , Annual Meeting , Legacy Genedx , Conference Call , Annual Report , Continuing Operations , Select Financial Information , Gross Margin , Consolidated Balance Sheets , Stockholder Equity , Consolidated Statements , Comprehensive Loss ,